These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8718594)

  • 21. [The cultivation of Bordetella pertussis under different conditions and a study of the cultures obtained].
    Nikolaeva VB; Roshchupkina MN; Gruber IM; Sviridov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):13-4. PubMed ID: 7661907
    [No Abstract]   [Full Text] [Related]  

  • 22. Surface antigens of Bordetella pertussis.
    Parker CD; Armstrong SK; Frank DW
    Adv Exp Med Biol; 1985; 185():117-27. PubMed ID: 2866677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of cyclodextrin as an agent to induce excretion of Bordetella pertussis antigens.
    Hozbor D; Rodriguez ME; Yantorno O
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):117-24. PubMed ID: 7804162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay.
    Mertsola J; Ruuskanen O; Kuronen T; Meurman O; Viljanen MK
    J Infect Dis; 1990 May; 161(5):966-71. PubMed ID: 2324547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.
    Gaines Das R; Xing D; Rigsby P; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):137-48. PubMed ID: 11580218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting human T cell responses against Bordetella species.
    De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A
    J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Virulence factors of Bordetella pertussis].
    Sato H
    Nihon Saikingaku Zasshi; 1996 Aug; 51(3):737-44. PubMed ID: 8840806
    [No Abstract]   [Full Text] [Related]  

  • 29. [The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition].
    Shmeleva EI; Mertsalova NU; Sukhinova EV; Kirillova GA; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Britsina MV; Ermolova EV; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):47-50. PubMed ID: 9245141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic pertussis serology in the recent clinical efficacy studies of acellular vaccines.
    Hallander HO
    Dev Biol Stand; 1997; 89():205-12. PubMed ID: 9272352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
    Nouchikian L; Roque C; Song JY; Rahman N; Ausar SF
    Vaccine; 2018 Sep; 36(38):5738-5746. PubMed ID: 30107994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pertussis antigens that abrogate bacterial adherence and elicit immunity.
    Brennan MJ; Shahin RD
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 2):S145-9. PubMed ID: 8876533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of serum treatment on pertussis antibody determination by ELISA.
    Tada Y; Ishikawa T; Chazono M; Yoshida I; Nii R
    Dev Biol Stand; 1991; 73():175-84. PubMed ID: 1778311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell surface antigens of Bordetella pertussis.
    Parker CD; Branes LV; Armstrong SK; Frank DW; Cole A
    Dev Biol Stand; 1985; 61():123-36. PubMed ID: 2872098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies.
    Selmer JC; Larsen FS; Hertz JB; Parton R
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):279-84. PubMed ID: 6097092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium.
    Idigbe EO; Parton R; Wardlaw AC
    J Med Microbiol; 1981 Nov; 14(4):409-18. PubMed ID: 6273564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.